ABSTRACT Zika virus (ZIKV) is a neurotropic virus that can cause a variety of neurological manifestations, ranging from mild forms to severe disorders like Guillain–Barré syndrome and congenital Zika syndrome. The pathophysiology of these complications is not fully understood, but they have been linked to host immune responses, particularly a proinflammatory Th1/Th17 profile. In this study, the kinetics of 14 cytokines were characterized in ZIKV‐infected patients recruited in French Guiana in 2016–2017. Cytokine concentrations were quantified using a multiplexed bead‐based immunoassay in serum samples collected sequentially from 36 patients during the first month after symptom onset. This longitudinal follow‐up provides chronological information on the immune response to mild‐to‐moderate ZIKV infection, with an early antiviral response dominated by IFN‐γ, TNF‐α and regulated by IL‐10, followed by a peak of Th1 and then Th17‐associated cytokines that persists for up to 1 month. The early presence of IL‐17A, IL‐21, and IL‐23 was positively correlated with the maximum amplitude of the serological response (total anti‐ZIKV IgG and seroneutralization titers), but also with the duration of neurological symptoms (paresthesia and muscle strength decrease), highlighting the bivalent role of Th17 immune response in ZIKV pathogenesis.
Marquine et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: